Equity Market Research
Friday, 23 February 2018
AJANTA PHARMA: Growth ingredients in place; EM execution + US approvals hold key says Motilal Oswal https://goo.gl/A57bFi
AJANTA PHARMA: Growth ingredients in place; EM execution + US approvals hold key says Motilal Oswal https://goo.gl/A57bFi
https://goo.gl/A57bFi
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment